Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia

Area of Science:

• Neonatal Medicine
• Pulmonary Biology
• Developmental Biology

Background:

• Increasing survival rates of extremely preterm infants correlate with a rise in bronchopulmonary dysplasia (BPD).
• BPD is a complex condition influenced by multiple antenatal and postnatal factors, leading to significant short- and long-term morbidities.
• The transforming growth factor beta (TGF-β) signaling pathway is crucial for lung development, injury repair, and fibrosis, and is implicated in BPD pathogenesis.

Purpose of the Study:

• To review the multifaceted role of TGF-β in both antenatal and postnatal lung development.
• To examine how established BPD risk factors influence the TGF-β signaling pathway.
• To analyze the impact of current and emerging BPD medications on TGF-β signaling.

Main Methods:

• Comprehensive literature review of studies on lung development, BPD, and TGF-β signaling.
• Analysis of research investigating the effects of antenatal and postnatal stressors on TGF-β.
• Evaluation of pharmacological interventions targeting TGF-β in the context of BPD.

Main Results:

• TGF-β plays a critical role in normal lung development and its dysregulation contributes to BPD.
• Antenatal and postnatal risk factors for BPD significantly modulate TGF-β pathway activity.
• Investigational and existing therapies for BPD demonstrate varying effects on TGF-β signaling.

Conclusions:

• The TGF-β pathway is a key player in the pathophysiology of BPD, influenced by various risk factors.
• Understanding TGF-β signaling provides insights into potential therapeutic strategies for preventing and treating BPD.
• Targeting the TGF-β pathway represents a promising avenue for novel BPD treatments.